News headlines about Stericycle (NASDAQ:SRCL) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Stericycle earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave news stories about the business services provider an impact score of 46.8623753526112 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the media headlines that may have effected Accern’s rankings:

Shares of Stericycle (SRCL) traded up $0.86 during mid-day trading on Friday, hitting $64.67. 1,292,624 shares of the stock traded hands, compared to its average volume of 1,310,000. Stericycle has a one year low of $58.53 and a one year high of $88.00. The firm has a market cap of $5,520.00, a price-to-earnings ratio of -52.15, a price-to-earnings-growth ratio of 1.45 and a beta of 0.41. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.90.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Wednesday, February 21st. The business services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.14 by ($0.14). The firm had revenue of $887.80 million during the quarter, compared to analyst estimates of $882.62 million. Stericycle had a net margin of 1.18% and a return on equity of 13.83%. Stericycle’s quarterly revenue was down 2.1% on a year-over-year basis. During the same period last year, the firm earned $1.00 EPS. sell-side analysts predict that Stericycle will post 4.58 earnings per share for the current year.

Several brokerages have recently issued reports on SRCL. Royal Bank of Canada decreased their price target on shares of Stericycle from $75.00 to $61.00 and set an “underperform” rating for the company in a report on Thursday, February 22nd. BidaskClub raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. Robert W. Baird raised shares of Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 price target for the company in a report on Tuesday, February 13th. BMO Capital Markets reissued a “hold” rating and issued a $72.00 price target on shares of Stericycle in a report on Wednesday, January 24th. Finally, Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $70.67.

In related news, Director Jack W. Schuler bought 10,000 shares of Stericycle stock in a transaction that occurred on Thursday, March 1st. The stock was purchased at an average cost of $62.59 per share, with a total value of $625,900.00. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 3.50% of the stock is currently owned by corporate insiders.

WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Insider Buying and Selling by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.